Daniel Lynch
Affiliations
- Director at Springworks Therapeutics Inc. (SWTX), 2025-05-15
- at 2Seventy Bio Inc. (TSVT), 2023-06-15
- Director at Bluebird Bio Inc. (BLUE), 2021-11-17
- Large Shareholder, Director at Xilio Therapeutics Inc. (XLO), 2021-10-22
- Director at Translate Bio Inc. (TBIO), 2021-02-16
- Director at Omega Alpha Spac (OMEG), 2021-01-07
- Director at Blueprint Medicines Corp (BPMC), 2020-06-26
- Director at Surface Oncology Inc. (SURF), 2020-06-12
- Director at Sesen Bio Inc. (SESN), 2019-06-21
- Director, Other at Dnib Unwind Inc. (BIND), 2016-08-30
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| SWTX | $61.24 | 3,582 | $219,348.78 | 82,944 | 2025-02-20 | Filing |
| SWTX | $60.14 | 44,018 | $2,647,185.30 | 86,526 | 2025-02-20 | Filing |
| SWTX | $60.00 | 400 | $24,000.00 | 130,544 | 2025-02-14 | Filing |
| SWTX | $55.51 | 65,600 | $3,641,751.20 | 130,944 | 2025-02-10 | Filing |
| SWTX | $54.88 | 39,634 | $2,175,046.54 | 196,544 | 2025-02-10 | Filing |